On August 2nd, 2020, CEO Nils Brünner presented in a livestream and explained and discussed the details in the press release that Scandion Oncology published on July 31st, 2020, about the results from the first three colorectal cancer patients receiving SCO-1010 in combination with FOLFIRI.
The recoreded live event can be viewed here: https://www.youtube.com/watch?v=IqnzEGGz2PM